# Texas Compounding Pharmacy, LLC: Form D filing

Texas Compounding Pharmacy, LLC, a pharmaceuticals company in Austin, TX, filed a Form D with the SEC in 2009. The latest, on June 19, 2009, reports $24,000 sold of a $120,000 offering to 6 investors.

Find out what Texas Compounding Pharmacy, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Texas%20Compounding%20Pharmacy%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Texas%20Compounding%20Pharmacy%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftexas-compounding-pharmacy-llc-1465901)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Texas%20Compounding%20Pharmacy%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Texas%20Compounding%20Pharmacy%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Ftexas-compounding-pharmacy-llc-1465901)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2924 BELGRAVE FALLS LN., Austin, TX, 78748
- Phone: (281) 660-8143
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Texas
- Year incorporated: 2009
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1465901

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 19, 2009 | New notice | $120,000 | $24,000 | $96,000 | 6 | Jun 11, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465901/000146590109000001/0001465901-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Rene Garza | Director |  |
| Jason Fisher | Director |  |
| Jared Leger | Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Jun 15, 2009](https://specstream.ai/data/form-d/week/2009-06-15) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Texas Compounding Pharmacy, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).